Skip to main content
. 2019 Jun 13;12:35. doi: 10.1186/s13072-019-0283-8

Table 1.

Protein expression and methylation status of SSTR5 in LSCC tumor tissues

Groups N Protein expression Methylation frequency (promoter) Methylation frequency (Exon 1)
n (%) P n (%) P n (%) P
Age
 < 60 25 9 (36.0) 4 (16.0) 13 (52.0)
 ≥ 60 23 7 (30.4) 0.683 5 (21.7) 0.611 14 (60.9) 0.536
Gender
 Male 46 15 (32.6) 9 (19.6) 26 (56.5)
 Female 2 1 (50.0) 0.610 0 (0.0) 0.488 1 (50.0) 0.856
Smoking
 Negative 10 4 (40.0) 2 (20.0) 5 (50.0)
 Positive 38 12 (31.6) 0.615 7 (18.4) 0.909 22 (57.9) 0.654
TNM stage
 I + II 19 10 (52.6) 3 (15.8) 7 (36.8)
 III + IV 29 6 (20.7) 0.022 6 (20.7) 0.671 20 (68.9) 0.028
Pathological differentiation of tumor
 Well 20 9 (45.0) 3 (15.0) 8 (40.0)
 Moderate 16 5 (31.3) 3 (18.7) 10 (62.5)
 Poor 12 2 (16.7) 0.252 3 (25.0) 0.782 9 (75.0) 0.128
LN metastasis
 Negative (N0) 22 11 (50.0) 4 (18.2) 8 (36.4)
 Positive (N1/2/3) 26 5 (19.2) 0.024 5 (19.2) 0.926 19 (73.1) 0.011